Medical College Of Wisconsin
Clinical trials sponsored by Medical College Of Wisconsin, explained in plain language.
-
New hope for Hard-to-Treat prostate cancer: drug targets key protein
Disease control Not yet recruitingThis study tests a drug called pacritinib in people with advanced prostate cancer that has stopped responding to hormone therapy. The goal is to see if it can slow or stop cancer growth. Participants must have a specific protein marker (STAT5) in their tumor. The study involves 3…
Phase: PHASE2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated May 26, 2026 04:17 UTC
-
New dual-targeting cell therapy takes on hard-to-treat blood cancers
Disease control Not yet recruitingThis early-stage study tests a new type of immunotherapy called h20.19 CAR T cells in 24 adults with B-cell lymphoma that has relapsed or not responded to prior treatments. The therapy uses a patient's own immune cells, modified to target two proteins (CD20 and CD19) on cancer ce…
Phase: PHASE1 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated May 26, 2026 04:16 UTC
-
New hope for elderly lymphoma patients: drug combo targets tough cancer
Disease control Not yet recruitingThis study tests whether adding two targeted drugs (mosunetuzumab and polatuzumab vedotin) to standard chemotherapy can help older adults (70+) with a newly diagnosed, aggressive type of lymphoma called diffuse large B-cell lymphoma. About 31 participants will receive this combin…
Phase: PHASE2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated May 26, 2026 04:16 UTC
-
Armored immune cells take on Hard-to-Treat myeloma
Disease control Not yet recruitingThis early-phase study tests a new kind of CAR T cell therapy for people with multiple myeloma that has returned or not responded to at least three prior treatments. The cells are 'armored' to resist signals from the cancer that normally shut them down. The main goal is to check …
Phase: PHASE1 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated May 26, 2026 04:14 UTC
-
Protein drinks during labor may help moms with diabetes keep blood sugar in check
Disease control Not yet recruitingThis study looks at whether high-protein drinks during labor can help pregnant women with insulin-treated diabetes maintain healthier blood sugar levels. About 60 women will be randomly assigned to drink either a clear protein beverage or standard clear liquids during labor. Part…
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated May 26, 2026 04:13 UTC
-
New hope for myeloma patients when CAR t fails: RECLAIM trial launches
Disease control Not yet recruitingThis study tests a drug called linvoseltamab in 34 adults with multiple myeloma whose cancer returned after BCMA CAR T-cell therapy. The goal is to see if this bispecific antibody can shrink tumors again. Participants must be at least 18 and have had CAR T therapy at least 6 mont…
Phase: PHASE2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated May 26, 2026 03:57 UTC
-
Brain zap and therapy may let surgeons remove more tumor safely
Disease control Not yet recruitingThis early study tests whether a device that stimulates the brain, combined with physical therapy, can help the brain rewire itself before surgery. The goal is to move important functions away from the tumor area so surgeons can remove more of the tumor without causing lasting ha…
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
Can online classes help puerto rican men shed pounds?
Disease control Not yet recruitingThis study tests if virtual, culturally tailored classes on healthy eating and physical activity can help Puerto Rican men lose at least 5% of their body weight. Forty-eight men over age 35 with a BMI of 25 or higher will join either the lifestyle program or a general health grou…
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
Could an HIV drug soothe your chronic throat burn?
Disease control Not yet recruitingThis study tests whether fosamprenavir, an FDA-approved HIV medication, can treat laryngopharyngeal reflux (LPR) in adults who did not improve with standard acid-reducing drugs. LPR causes chronic cough, hoarseness, and throat clearing, and current treatments often fail. About 10…
Phase: PHASE2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Blood test after delivery could prevent deadly postpartum complications
Disease control Not yet recruitingThis study tests whether a blood test before delivery can identify women at high risk for developing dangerous high blood pressure after giving birth. About 60 pregnant women with risk factors will be enrolled, and those found to be high-risk will receive extra monitoring and car…
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated May 20, 2026 11:58 UTC
-
Personalized Post-Transplant therapy aims to stop cancer return
Disease control Not yet recruitingThis study tests whether giving personalized maintenance therapy after a stem cell transplant can prevent cancer from coming back in people with certain blood cancers (like acute myeloid leukemia or myelodysplastic syndromes). About 450 adults will be assigned to receive or not r…
Phase: PHASE2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated May 19, 2026 11:59 UTC
-
Experimental vaccine combo targets brain metastases in first human trial
Disease control Not yet recruitingThis early-phase study tests whether a special cancer vaccine (SV-BR-1-GM) combined with an immunotherapy drug (pembrolizumab) is safe and feasible for people with solid tumors that have spread to the brain or spinal cord. About 20 adults whose cancer has worsened after standard …
Phase: PHASE1 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated May 19, 2026 11:47 UTC
-
New hope for Hard-to-Treat myeloma: CAR T-Cells join forces with daratumumab
Disease control Not yet recruitingThis early-phase study tests a new treatment called FT836 CAR T-cell therapy combined with daratumumab in 12 adults with multiple myeloma that has returned or not responded to at least three prior treatments. The main goal is to check safety and find the right dose. Participants …
Phase: PHASE1 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated May 18, 2026 12:06 UTC
-
Could a simple supplement fix heart vessels? new study tests propionic acid
Disease control Not yet recruitingThis study tests whether a dietary supplement called propionic acid (a substance made by gut bacteria) can improve blood vessel function in 20 people with coronary artery disease. Participants will take the supplement for 4 weeks, and researchers will measure changes in artery he…
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated May 18, 2026 12:02 UTC
-
Diabetes drug may also fight fatty liver
Disease control Not yet recruitingThis study looks at whether a GLP-1 RA drug (used for diabetes and weight loss) can improve fat levels in the liver and blood of people with MASLD (fatty liver disease). About 30 adults with MASLD, diabetes, and obesity will take the drug and have liver biopsies and blood tests t…
Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Light therapy may soothe cancer Kids' mouth sores
Prevention Not yet recruitingThis study tests if light therapy can prevent and treat painful mouth sores in children with cancer. About 50 kids will receive light therapy every other day while in the hospital. Researchers will compare their results to past patients who did not get the therapy. The goal is to…
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Prevention
Last updated May 20, 2026 11:55 UTC
-
New hope against recurrent c. diff: common bile acid shows promise
Prevention Not yet recruitingThis early-phase study tests whether adding a bile acid called UDCA to standard antibiotics can stop C. diff colitis from returning. About 30 adults with high-risk C. diff will take UDCA for up to 8 weeks alongside their usual treatment. Researchers will track recurrence through …
Phase: EARLY_PHASE1 • Sponsor: Medical College of Wisconsin • Aim: Prevention
Last updated May 20, 2026 11:55 UTC
-
Healthy habits before pregnancy may cut risks, new study tests
Prevention Not yet recruitingThis study tests whether teaching women about healthy eating, activity, and other lifestyle habits before or during early pregnancy can improve their heart health and lower the chance of problems like gestational diabetes and preeclampsia. Two hundred women at risk for these issu…
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Prevention
Last updated May 18, 2026 12:02 UTC
-
Mindfulness and wearable tech aim to prevent dangerous pregnancy condition
Prevention Not yet recruitingThis study tests whether mindfulness training, with or without wearable biosensors, can help prevent preeclampsia in pregnant women at moderate to high risk. 90 women will be randomly assigned to one of three groups: mindfulness plus biosensors, mindfulness alone, or standard pre…
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Prevention
Last updated May 15, 2026 11:56 UTC
-
New hope for stubborn heartburn: experimental drug targets symptoms
Symptom relief Not yet recruitingThis study tests whether a drug called Fosamprenavir-Sodium Alginate (FOS-SA) can reduce heartburn and regurgitation in people whose acid reflux doesn't improve with standard proton pump inhibitors (PPIs). About 60 adults aged 18-65 will take either FOS-SA or a placebo twice dail…
Phase: PHASE2 • Sponsor: Medical College of Wisconsin • Aim: Symptom relief
Last updated May 26, 2026 04:24 UTC
-
Spinal zaps may restore balance after neck surgery
Symptom relief Not yet recruitingThis study tests whether a gentle electrical stimulation of the spinal cord, combined with balance exercises, can improve balance in adults who still have trouble walking steadily after surgery for a neck condition called degenerative cervical myelopathy. About 45 participants wi…
Phase: PHASE1, PHASE2 • Sponsor: Medical College of Wisconsin • Aim: Symptom relief
Last updated May 22, 2026 13:54 UTC
-
Diet and exercise program aims to boost strength and quality of life in myeloma patients
Symptom relief Not yet recruitingThis study tests whether a 16-week lifestyle program focused on healthy eating and exercise can improve physical function, quality of life, and blood markers of aging in people with multiple myeloma. About 184 adults who have had myeloma for at least a year will take part. Partic…
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Symptom relief
Last updated May 19, 2026 11:59 UTC
-
New tool aims to shield cancer Survivors' hearts
Knowledge-focused Not yet recruitingThis study tests a new tool that helps doctors and cancer survivors decide together on the best heart-protecting medications and heart scans. About 60 adult cancer survivors who have not yet seen a heart specialist will take part. The goal is to see if the tool is easy to use and…
Sponsor: Medical College of Wisconsin • Aim: Knowledge-focused
Last updated May 26, 2026 04:20 UTC
-
Quercetin: a natural boost for blood vessels?
Knowledge-focused Not yet recruitingThis study looks at whether the supplement quercetin can improve how small blood vessels function in people with obesity. Forty adults aged 18-40 with a BMI over 30 will take quercetin and have their blood vessel health measured using cameras and small sensors placed on the skin.…
Phase: PHASE2 • Sponsor: Medical College of Wisconsin • Aim: Knowledge-focused
Last updated May 26, 2026 04:18 UTC
-
Study aims to uncover why exercise spikes blood pressure in diabetes
Knowledge-focused Not yet recruitingThis study looks at why people with type 2 diabetes have dangerously high blood pressure during exercise, which raises their risk of heart attack and stroke. Researchers will test if poor blood vessel function and cell damage cause this problem. The goal is to find new ways to ma…
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Knowledge-focused
Last updated May 26, 2026 04:18 UTC
-
Anti-Aging supplement TA-65 put to the test in blood vessel study
Knowledge-focused Not yet recruitingThis study looks at whether a dietary supplement called TA-65 can help blood vessels work better as people age. Researchers will measure blood vessel function in healthy younger and older adults, as well as people with coronary artery disease. The goal is to see if activating tel…
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Knowledge-focused
Last updated May 26, 2026 04:17 UTC
-
Heart disease prevention gets a genetic upgrade in rural and urban clinics
Knowledge-focused Not yet recruitingThis study looks at whether adding a person's genetic risk score to standard heart disease risk checks helps doctors and patients decide together on prevention steps, like taking statins. About 200 adults aged 40-69 with no prior heart disease or statin use will take part in prim…
Sponsor: Medical College of Wisconsin • Aim: Knowledge-focused
Last updated May 26, 2026 04:13 UTC
-
Tiny trial aims to see if gallium can sneak into brain tumors
Knowledge-focused Not yet recruitingThis very early (Phase 0) study will give an oral drug called gallium maltolate to 8 people whose glioblastoma has come back. The main goal is to measure how much gallium gets into the tumor tissue after surgery, compared to untreated tumor samples. This trial does not test if th…
Phase: EARLY_PHASE1 • Sponsor: Medical College of Wisconsin • Aim: Knowledge-focused
Last updated May 22, 2026 14:01 UTC
-
Sticker thermometer could replace painful probes for sick kids
Knowledge-focused Not yet recruitingThis study tests a new, non-invasive forehead thermometer (Temple Touch Pro) in children in the pediatric intensive care unit who need precise temperature control. The goal is to see if this simple sticker-like device can accurately replace internal probes placed in the bladder, …
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC
-
Brain protein may predict Post-Drug weight gain
Knowledge-focused Not yet recruitingThis study aims to find out why some people regain weight after stopping an injectable weight loss drug. Researchers will measure a brain protein called AgRP in 52 adults whose insurance coverage for the drug is ending. They will track weight changes and hunger levels for 3 month…
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC
-
New biobank aims to unlock better treatments for blood disorders
Knowledge-focused Not yet recruitingThis study collects blood samples and medical information from 375 people with non-cancerous blood diseases like aplastic anemia, sickle cell disease, or thalassemia who are receiving a stem cell transplant or gene therapy. Researchers will use the samples to understand why treat…
Sponsor: Medical College of Wisconsin • Aim: Knowledge-focused
Last updated May 20, 2026 11:53 UTC
-
Diet drinks under the microscope: new study targets heart risks in young diabetics
Knowledge-focused Not yet recruitingThis study looks at how non-nutritive sweeteners (like those in diet drinks) affect the heart and blood vessels of young adults with type 1 diabetes. Twenty people aged 15-24 will drink a sports drink and have their blood vessel function measured. The goal is to understand if the…
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Knowledge-focused
Last updated May 11, 2026 20:39 UTC